Green Cross seeking a new type of Parkinson therapeutic drug.

Published: 2005-08-18 07:00:00

Updated: 2005-08-18 07:00:00

Green Cross announced a joint research project with Prof. Kim Hyeong-choon of Gangwon Univ. College of Pharmacy for a new type of drug for the treatment of Parkinson disease, GC-PS05 and its derivatives and the completion of their patent application in 10 overseas countries including America.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK